Elevated plasma substance P in sickle cell disease and vaso-occlusive crisis.
Douglas
Steven D
SD
D000755:Anemia, Sickle Cell / Q000097:blood* / Q000150:complications*; D000932:Antiemetics / Q000627:therapeutic use; D000077608:Aprepitant; D017321:Clinical Trials, Phase I as Topic; D006801:Humans; D018448:Models, Immunological; D009025:Morpholines / Q000627:therapeutic use; D064729:Neurokinin-1 Receptor Antagonists; D010146:Pain / Q000097:blood / Q000188:drug therapy / Q000209:etiology; D013373:Substance P / Q000097:blood*
D000932:Antiemetics; D009025:Morpholines; D064729:Neurokinin-1 Receptor Antagonists; D000077608:Aprepitant; D013373:Substance P